Fine needle aspiration biopsy of intraparotid spindle cell lipoma: A case report
Department of Pathologic Anatomy and Oncology, A.O.U. "San Giovanni di Dio e Ruggi d'Aragona"via S. Leonardo, Salerno, Italy. . Diagnostic Cytopathology
(Impact Factor: 1.12).
02/2013; 41(2). DOI: 10.1002/dc.21801
Intraparotid spindle cell lipoma (SCL) of the salivary gland is a rare entity. Review of the literature revealed only two previous reports describing its cytological features. We report a case of a 44-year-old man who complained for a slowly growing, asymptomatic mass in the left parotid gland that since 12 months. Fine needle aspiration biopsy (FNAB) showed a loose collections of bland-appearing spindle cells in a myxoid background admixed with capillary fragments and some mature fat cells suggesting a diagnosis of SCL. A cytological diagnosis of mesenchymal myxoid spindle cell tumor with lipomatous differentiation, possibly an intraparotideal SCL was performed. Histological examination of the mass and the positive immunostaining for CD34 and negativity for S-100, CK-cocktail, and actin confirmed the diagnosis of SCL. The diagnosis of intraparotid SCL can be made by examining cytologic material containing mature fat with bland spindle cells in a myxoid background. FNAB diagnosis on SCL also allows to rule out other primary salivary gland tumors that may be clinically and instrumentally indistinguishable and thereby permits an appropriate surgical procedure to ensue. © 2011 Wiley Periodicals, Inc.
Figures in this publication
- "Standard criteria were employed to classify tumors and their variants . FNC was performed and classified according to the British Thyroid Association  as described elsewhere [36,37]. As far as the concomitant lymphoid infiltrate concerns, its polyclonal, inflammatory nature was assessed in selected cases by flow cytometry (FC) and related data were interpreted accordingly [38-41] in this specific clinical and anatomical setting. "
[Show abstract] [Hide abstract]
Thyroid cancer is a rare disease characterized by the subtle appearance of a nodule. Fine-needle cytology (FNC) is the first diagnostic procedure used to distinguish a benign from a malignant nodule. However, FNC yields inconclusive results in about 20% of cases. BRAFV600E mutation is the most frequent genetic alteration in papillary thyroid carcinoma (PTC); its high prevalence makes this oncogene a useful marker to refine inconclusive FNC results. However, the prevalence of the BRAFV600E mutation depends on detection methods, geographical factors, and age. The aim of this study is to determine the prevalence of BRAFV600E mutation and its utility as a diagnostic tool in elderly subjects.
FNC from 92 PTC patients were subjected to the analysis of BRAF mutation by pyrosequencing and direct sequencing; age-dependent prevalence was also determined.
BRAF mutation analysis was successful in all FNC specimens. BRAFV600E was documented in 62 (67.4%) and in 58 (63.0%) PTCs by pyrosequencing and direct sequencing, respectively. BRAFV600E prevalence did not correlate with patient's age at diagnosis. Twenty out of 32 PTCs (62.5%) were correctly diagnosed by BRAF mutation analysis in inconclusive FNC results.
Detection of BRAFV600E in cytology specimens by pyrosequencing is a useful diagnostic adjunctive tool in the evaluation of thyroid nodules also in elderly subjects.
BMC Surgery 10/2013; 13(Suppl 2):S37. DOI:10.1186/1471-2482-13-S2-S37 · 1.40 Impact Factor
- "No relevant lymph nodes were detected. The patient underwent US-guided FNC with rapid on-site evaluation (ROSE), as previously described [47,48]. The diagnostic procedure and its related risks were first discussed with the patient, who was informed that 1 or 2 additional passes might have been needed, and an informed consent was obtained. "
[Show abstract] [Hide abstract]
Amyloidosis is a systemic disease characterized by the extracellular deposition of amyloid fibrils in different organs and tissues. The thyroid gland may be affected by diffuse or nodular amyloid deposits, along with multiple myeloma (MM) (Amyloid Light-Chain Amyloidosis, AL amyloidosis) or chronic inflammatory diseases (Amyloid A Amyloidosis, AA amyloidosis), but thyroid gland involvement rarely appears as the first clinical manifestation in both conditions. The present study reports a case of primary thyroidal nodular amyloid goiter diagnosed by fine-needle cytology (FNC) in an elderly patient.
A 66-year-old female patient presented with dysphagia and hoarseness; the patient suffered from rheumatoid arthritis but did not have kidney failure or altered thyroid function. Ultrasound examination (US) showed a 30 mm irregular, hypoechoic area in the left thyroid lobe. FNC showed abundant, dense and amorphous material similar to the one stained in purple at Diff-Quik stain and pinkish at the Papanicolaou. Spindle cells with thin, bland and bent nuclei were scattered in this material; few thyroid follicular cells were also present. An alcohol-fixed smear was stained with Congo red: the amyloid material appeared cherry red and it also showed apple-green birefringence when observed with a polarizing microscope. A differential diagnosis between different thyroid pathologies was considered and the cytological diagnosis of nodular amyloid goiter was pointed out. The patient underwent thyroid lobectomy and the subsequent histological examination confirmed the cytological diagnosis.
FNC is a safe and effective procedure for the diagnosis of thyroid amyloidosis. Congo red-stained smears can be used to demonstrate the presence of amyloid material, showing the typical green birefringence under polarized light. An early and accurate cytological diagnosis may suggest an hematological screening and the appropriate treatment for the thyroid nodule.
BMC Surgery 10/2013; 13(Suppl 2):S43. DOI:10.1186/1471-2482-13-S2-S43 · 1.40 Impact Factor
Available from: Alfredo Garzi
- "Indeed, the material aspirated through FNC can be used not only for the morphological assessment, but also for ancillary techniques which include ICC, as well as flow cytometry, hybridization techniques, and molecular biology techniques [14,16,20,24,26,32-34,36,42,55]. Nonetheless, the diagnosis of soft tissue tumors on cytological samples is complex and extreme caution is required in the exact classification of spindle-cell tumors by FNC, as this may have a major impact on patient management [5,10,22,36]. Despite the variety of possible mesenchymal and non mesenchymal lesions with a spindle cell cytological pattern, conventional smears allow the evaluation of relative few parameters such as cellularity, cell features, patterns and background; therefore, conventional techniques have to be coupled with ICC, and require a precise clinical history and accurate imaging. "
[Show abstract] [Hide abstract]
Fibrosarcoma (FS) accounts for about 3% of all soft tissue sarcomas. It may arise in any area of the body, but it is relative rare in the head and neck district. Fine-needle cytology (FNC) is widely used in the diagnosis of neoplastic and non-neoplastic lesions of soft tissue. This article describes a case of FS of the neck diagnosed by FNC.
FNC was performed in a sub-fascial supraclavicular mass of an elderly patient under ultrasound (US) control. FNC was used to prepare cytological smears that were conventionally and immunocytochemically (ICC) stained.
Smears showed a monomorphous spindle cell population and were positive at ICC for Vimentin and negative for CKAE1AE3, Actin, S-100, CD68, CT and PAX-8. The cytological diagnosis was confirmed by histological diagnosis. The patient underwent surgical resection and subsequent radiotherapy.
FNC diagnosis of FS is reliable and accurate and may be conveniently used in the scheduling of surgical procedures, when needed, avoiding the treatment of benign nodules.
BMC Surgery 10/2013; 13(2). DOI:10.1186/1471-2482-13-S2-S42 · 1.40 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.